Absorption |
Blood-Brain Barrier | BBB+ | 0.9882 |
Human Intestinal Absorption | HIA+ | 0.9971 |
Caco-2 Permeability | Caco2+ | 0.8867 |
P-glycoprotein Substrate | Substrate | 0.8787 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8782 |
Non-inhibitor | 0.9560 |
Renal Organic Cation Transporter | Inhibitor | 0.6221 |
Distribution |
Subcellular localization | Mitochondria | 0.5027 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7451 |
CYP450 2D6 Substrate | Substrate | 0.8919 |
CYP450 3A4 Substrate | Substrate | 0.7375 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.5191 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9046 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.6470 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8155 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9176 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7503 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8367 |
Non-inhibitor | 0.8740 |
AMES Toxicity | Non AMES toxic | 0.9132 |
Carcinogens | Non-carcinogens | 0.9634 |
Fish Toxicity | High FHMT | 0.8786 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.8762 |
Honey Bee Toxicity | Low HBT | 0.6069 |
Biodegradation | Not ready biodegradable | 0.9944 |
Acute Oral Toxicity | II | 0.7376 |
Carcinogenicity (Three-class) | Non-required | 0.6614 |